What is the appropriate management for a patient with Candida albicans overgrowth and a few Enterococcus faecalis colonies?

Management of Candida albicans and Enterococcus faecalis Co-infection

Treatment should focus primarily on the Candida albicans, as the presence of "few" Enterococcus faecalis colonies typically represents colonization rather than true infection and does not require specific antimicrobial therapy in most clinical contexts.

Clinical Context Assessment

The critical first step is determining where these organisms were isolated:

• Urine culture: Most common scenario for this combination
• Respiratory secretions: Almost always colonization
• Blood culture: Requires aggressive treatment
• Wound/abscess: May require source control
• Root canal/dental: Specialized endodontic management

Site-Specific Management

Urinary Tract (Most Likely Scenario)

For symptomatic cystitis with Candida albicans:

• Oral fluconazole 200 mg daily for 14 days 1
• Remove indwelling bladder catheter if present (strongly recommended) 1
• The "few" E. faecalis colonies typically do not require specific antibacterial therapy unless the patient has clear signs of bacterial UTI (dysuria, frequency, pyuria)

For asymptomatic candiduria:

• No treatment is generally indicated unless the patient is undergoing urologic procedures or is severely immunocompromised
• Catheter removal alone often resolves the issue 1

For pyelonephritis or ascending infection:

• Oral fluconazole 200-400 mg (3-6 mg/kg) daily for 14 days 1
• Eliminate any urinary tract obstruction 1
• Consider imaging if symptoms persist

Respiratory Secretions

Growth of Candida from respiratory secretions usually indicates colonization and rarely requires treatment with antifungal therapy 1. The same applies to E. faecalis in this context. Do not treat unless there is clear evidence of invasive disease.

Bloodstream Infection (Candidemia)

If either organism is isolated from blood:

For Candida albicans candidemia:

• An echinocandin is preferred for initial therapy: caspofungin (70 mg loading, then 50 mg daily), micafungin (100 mg daily), or anidulafungin (200 mg loading, then 100 mg daily) 1
• Alternative: fluconazole 800 mg loading, then 400 mg daily (only if patient is not critically ill and no recent azole exposure)
• Remove central venous catheters 1
• Continue for 14 days after blood culture clearance and symptom resolution

For E. faecalis bacteremia:

• Requires separate antibacterial therapy based on susceptibilities (ampicillin if susceptible, vancomycin if resistant)

Oropharyngeal/Esophageal Candidiasis

For mild oropharyngeal disease:

• Clotrimazole troches 10 mg 5 times daily for 7-14 days 1
• Alternative: nystatin suspension 4-6 mL 4 times daily 1

For moderate to severe oropharyngeal disease:

• Oral fluconazole 100-200 mg daily for 7-14 days 1

For esophageal candidiasis:

• Oral fluconazole 200-400 mg daily for 14-21 days 1
• Systemic therapy is always required 1

Intra-abdominal Infection

If isolated from intra-abdominal source:

• Treat the same as candidemia with echinocandin therapy 1
• Source control with drainage/debridement is mandatory 1
• Duration determined by adequacy of source control and clinical response 1

Key Clinical Pitfalls

Common mistake #1: Treating asymptomatic candiduria or colonization

• Only treat if symptomatic, undergoing urologic procedures, or severely immunocompromised
• Catheter removal is more important than antifungal therapy 1

Common mistake #2: Assuming "few" E. faecalis requires antibiotics

• Small numbers of enterococci often represent colonization, particularly in urine or respiratory specimens
• Treat E. faecalis only if there are clear signs of bacterial infection (fever, leukocytosis, pyuria with symptoms)

Common mistake #3: Using fluconazole empirically in critically ill patients

• Echinocandins are preferred for unstable patients or those with recent azole exposure 2
• Fluconazole is acceptable only for stable patients without azole-resistant risk factors 2

Common mistake #4: Inadequate duration of therapy

• Candidemia requires 14 days after blood culture clearance, not from start of therapy 1

Special Populations

HIV-infected patients:

• Antiretroviral therapy is strongly recommended to reduce recurrence 1
• Same antifungal regimens apply

ICU patients with risk factors:

• Consider empiric echinocandin therapy if septic shock with candidiasis risk factors 1
• Do not wait for culture confirmation in hemodynamically unstable patients

Neutropenic patients:

• Require more aggressive initial therapy with echinocandins or lipid formulation amphotericin B

Monitoring Response

• Repeat cultures 3-5 days after starting therapy to document clearance
• Clinical improvement should occur within 3-5 days
• If no improvement, consider resistance, inadequate source control, or alternative diagnosis
• Ophthalmologic examination if candidemia persists or in high-risk patients